Related Experiment Video
Updated: Jul 9, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Anticancer drugs designed by mother nature: ancient drugs but modern targets
Haruyo Ichikawa1, Yutaka Nakamura, Yoshiki Kashiwada
1International Research and Educational Institute for Integrated Medical Sciences (IREIIMS), Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Abstract:
Nuclear factor-kappaBeta (NF-kappaBeta) is a transcription factor that is activated in response to various inflammatory stimuli such as cytokines, growth factors, hormones, mitogens, carcinogens, chemotherapeutic agents, viral products, eukaryotic parasites, endotoxin, fatty acids, metals, radiation, hypoxia, and psychological, physical, oxidative, and chemical stresses. In addition, constitutively active NF-kappaBeta is frequently encountered in a wide variety of tumors. Furthermore, NF-kappaBeta activation has been shown to regulate the expression of over 400 genes involved in cellular transformation, proliferation, inflammation, viral replication, antiapoptosis, angiogenesis, invasion and metastasis, oxidative stress, and osteoclastogenesis. Therefore, because of the critical role NF-kappaBeta plays in the pathogenesis of cancer, specific inhibitors of this factor are being sought. Agents that prevent cancer or inflammation have been found to suppress NF-kappaBeta activation. Numerous reports indicate that ancient plants and their components are potent as NF-kappaB inibitors. However, ancient medicine such as traditional Chinese medicine, Kampo, Ayurveda requires rediscovery in light of our current knowledge of allopathic (modern) medicine for the therapeutic and preventive purpose. In this review, we present evidence that numerous agents identified from fruits and vegetables can interfere with NF-kappaBeta pathway. The structure of drugs and their relationship with NF-kappaBeta inhibitory activity is discussed.
Insights
Nuclear factor-kappaBeta (NF-kappaBeta) is crucial in cancer and inflammation. This review highlights fruits and vegetables as natural sources of NF-kappaBeta inhibitors, offering potential for cancer prevention and treatment.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Nuclear factor-kappaBeta (NF-kappaBeta) is a key transcription factor activated by diverse stimuli, including inflammatory agents, carcinogens, and stresses.
- Constitutively active NF-kappaBeta is prevalent in various tumors, regulating over 400 genes linked to cancer progression, inflammation, and metastasis.
- NF-kappaBeta's critical role in pathogenesis necessitates the search for specific inhibitors for cancer and inflammation prevention.
Purpose of the Study:
- To review evidence on agents from fruits and vegetables that inhibit the NF-kappaBeta pathway.
- To explore the relationship between drug structure and NF-kappaBeta inhibitory activity.
- To re-evaluate traditional medicine's potential in light of modern scientific understanding for therapeutic and preventive applications.
Main Methods:
- Literature review of studies investigating NF-kappaBeta inhibitors.
- Analysis of plant-derived compounds, particularly from fruits and vegetables.
- Discussion of structure-activity relationships for NF-kappaBeta inhibition.
Main Results:
- Numerous agents from fruits and vegetables demonstrate interference with the NF-kappaBeta pathway.
- Ancient plants and their components are identified as potent NF-kappaB inhibitors.
- The review discusses the structural basis for the inhibitory activity of these agents.
Conclusions:
- Fruits and vegetables contain compounds that can inhibit the NF-kappaBeta pathway, suggesting a role in cancer prevention.
- Rediscovering and validating traditional medicine principles with modern scientific methods is crucial for developing new therapies.
- Understanding the structure-activity relationship of natural compounds can guide the development of novel NF-kappaBeta inhibitors.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
